Increased Smad signaling and reduced MRF expression in skeletal muscle from obese subjects
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Objective: The molecular mechanisms underpinning the loss of skeletal muscle mass and strength associated with insulin resistance remain to be extensively investigated. There is mounting recognition that certain ligands of the transforming growth factor (TGF)‐β family are upregulated in insulin resistant states, including obesity. This study analyses the expression of potent ligands of this family, TGF‐β1 and myostatin (MSTN) and downstream components of the canonical TGF‐β family signaling pathway (Smads) in skeletal muscle from lean and insulin resistant obese subjects. Design and Methods: Biopsies taken from the rectus abdominis muscle of lean (n = 13) and obese subjects (n = 20) were analyzed for the expression of TGF‐β1 and MSTN as well as TGF‐β signaling components, Smad2, 3, and 4, and transcription of the muscle regulatory factors (MRFs), MyoD and myogenin. Results: Increases in Smad2 and Smad3 phosphorylation, Smad4 and total Smad3 were observed to be coincident with altered transcription of MyoD and myogenin. TGF‐β1 and MSTN protein levels were not significantly altered. Conclusion: Thus, increased Smad signaling is likely to account for, at least, a proportion of obesity and insulin resistance‐related muscle atrophy through reduced MRF, particularly MyoD, transcription. The major regulatory ligand may not be MSTN and further members of the TGF‐β1 superfamily should be considered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Muniyappa, R., Lee, S., Chen, H., & Quon, M. J. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00645.2007 · Cited by 1,643
Inflammation and insulin resistance
de Luca, C., & Olefsky, J. M. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.11.057 · Cited by 1,161
Accelerated Loss of Skeletal Muscle Strength in Older Adults With Type 2 Diabetes
Park, S. W., Goodpaster, B. H., Strotmeyer, E. S., Kuller, L. H., Broudeau, R., Kammerer, C., de Rekeneire, N., Harris, T. B., Schwartz, A. V., Tylavsky, F. A., et al. (2007) · Diabetes Care · doi:10.2337/dc06-2537 · Cited by 766
Gonzalez-Cadavid, N. F., Taylor, W. E., Yarasheski, K., Sinha-Hikim, I., Ma, K., Ezzat, S., Shen, R., Lalani, R., Asa, S., Mamita, M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14938 · Cited by 571 · cited 1×
“The inactivation of MSTN results in a hypermuscular phenotype (3), whilst over-expression induces atrophy and is implicated in wasting in a variety of disease states, including HIV (4).”
BackgroundGuo, T., Jou, W., Chanturiya, T., Portas, J., Gavrilova, O., & McPherron, A. C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004937 · Cited by 402 · cited 2×
“Whilst increased TGF-b1 release into the circulation of insulin resistant patients has been described (15), research has primarily focused on increased MSTN abundance (5) and its corresponding metabolic effects when reduced, such as prevention of diet-induced obesity and improved insulin-sensitivity (7,8).”
BackgroundLiu, D., Black, B. L., & Derynck, R. (2001) · Genes & Development · doi:10.1101/gad.925901 · Cited by 399
Increased secretion and expression of myostatin in skeletal muscle from extremely obese women
Hittel, D. S., Berggren, J. R., Shearer, J., Boyle, K., & Houmard, J. A. (2009) · Diabetes · doi:10.2337/db08-0943 · Cited by 324 · cited 2×
“Whilst increased TGF-b1 release into the circulation of insulin resistant patients has been described (15), research has primarily focused on increased MSTN abundance (5) and its corresponding metabolic effects when reduced, such as prevention of diet-induced obesity and improved insulin-sensitivity (7,8).”
BackgroundFriedman, J. E., Ishizuka, T., Shao, J., Huston, L., Highman, T., & Catalano, P. (1999) · Diabetes · doi:10.2337/diabetes.48.9.1807 · Cited by 255
Allen, D. L., Cleary, A. S., Speaker, K. J., Lindsay, S. F., Uyenishi, J., Reed, J. M., Madden, M. C., & Mehan, R. S. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00798.2007 · Cited by 183 · cited 1×
“MSTN is upregulated in myotubes isolated from insulin resistant obese women (5) and the skeletal muscle of obese mice (6).”
Background
Cited by
Muscle wasting in disease: molecular mechanisms and promising therapies
Cohen, S., Nathan, J. A., & Goldberg, A. L. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4467 · Cited by 1,089
The effects of obesity on skeletal muscle regeneration
Akhmedov, D., & Berdeaux, R. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00371 · Cited by 241
The extracellular matrix and insulin resistance
Williams, A. S., Kang, L., & Wasserman, D. H. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.05.006 · Cited by 228
Parker, L., Caldow, M. K., Watts, R., Levinger, P., Cameron-Smith, D., & Levinger, I. (2017) · European Journal of Applied Physiology · doi:10.1007/s00421-017-3639-4 · Cited by 36
Self-citationChen, L., Su, X., & Hu, Y. (2020) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s275301 · Cited by 10
Metadata
- Authors
- Watts, R., McAinch, A. J., Dixon, J. B., O'Brien, P. E., & Cameron‐Smith, D.
- Venue
- Obesity
- Publisher
- Wiley
- Published
- 2013-03
- Volume
- 21
- Issue
- 3
- Pages
- 525-528
- ISSN
- 1930-7381 (ISSN-L)
- 1930-739X
- OpenAlex
- W2066849968
- Cited by
- 50
- References
- 9
- FWCI
- 1.34
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Increased Smad signaling and reduced MRF expression in skeletal muscle from obese subjects. https://app.cochat.ai/papers/10.1002/oby.20070
- The paper
- Watts, R., McAinch, A. J., Dixon, J. B., O'Brien, P. E., & Cameron‐Smith, D. (2013). Increased Smad signaling and reduced MRF expression in skeletal muscle from obese subjects. Obesity. https://doi.org/10.1002/oby.20070
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.